Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides

NCT05282485 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT05282485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Completed
Start date
June 2, 2022
Completion date
June 25, 2026
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast feeding, hiv, infant morbidity